4340 Duncan Avenue St. Louis, MO 63110 314-615-6355 info@biogenerator.org

News

BioGenerator News

We’ve Moved!

Aug 13, 2019

We are excited to get to work in our new office. More than just bringing all of BioSTL’s components under one roof, our new headquarters in Cortex Innovation Community will […]

Read More

BAYER AWARDS $1.5 MILLION GRANT TO BIOSTL TO SUPPORT ORGANIZATION’S HEADQUARTERS AND PROGRAM EXPANSION IN ST. LOUIS’ EMERGING TECHNOLOGY DISTRICT

Aug 06, 2019

ST. LOUIS, Aug. 6, 2019 – Bayer has awarded BioSTL, a St. Louis-based non-profit which advances and promotes the region’s growing bioscience, innovation and technology community, a $1.5 million grant […]

Read More

BioGenerator company MediBeacon enters into commercialization partnership with Huadong Medicine

Jul 31, 2019

MediBeacon Enters into $30 Million Investment and Exclusive Commercialization Partnership in Greater China with Huadong Medicine MediBeacon and Huadong Medicine will collaboratively work to reach regulatory approval on MediBeacon’s entire […]

Read More

New BioSTL building at Cortex brings support for bioscience startups under one roof

Jul 25, 2019

Bioscience startups can find free resources and support at a renovated building in the Cortex district of St. Louis. BioSTL, a nonprofit organization that has launched 150 St. Louis-based startups […]

Read More

BioGenerator Wins $750,000 Federal Grant to Build New St. Louis Agtech Companies

Jul 24, 2019

Grant expands BioGenerator Labs and Commercialization Resources ST. LOUIS – BioGenerator, the investment arm of BioSTL, has won a $750,000 grant from the U.S. Department of Commerce Economic Development Administration […]

Read More

BioGenerator and Synchrony Bio lead initial financing for Readout, a Digital Health Startup

Jun 13, 2019

Readout adds veteran executive leadership to its management team ST. LOUIS – Readout, an early-stage digital health company, announced completion of its initial funding round, led by BioGenerator, the investment […]

Read More

BioGenerator Company Adarza BioSystems Reaches Commercialization Stage, Launches ZIVA Platform

May 02, 2019

Adarza BioSystems to reveal ZIVA platform at AAI 2019: a fully automated protein multiplex detection system ST. LOUIS (May 2, 2019) — Biotech startup Adarza Biosystems, Inc. announced today that […]

Read More

BioGenerator Company Canopy Biosciences Raises Series B Led By Ampersand, Acquires Zellkraftwerk

Apr 30, 2019

Press release:  https://canopybiosciences.com/news/canopy-biosciences-acquires-zellkraftwerk-gmbh/   Acquisition gives St. Louis-based Canopy an international reach Article by David Nicklaus Expanding internationally, being backed by a prominent private equity firm and tripling in size […]

Read More

Backed by Atlas Venture, BioGenerator Company Indalo Therapeutics Begins Clinical Program

Apr 18, 2019

Indalo Therapeutics Initiates Dosing in Phase 1 Clinical Trial of Lead Antifibrotic Drug Candidate IDL-2965  – Oral integrin antagonist inhibits multiple processes of pathologic fibrosis – Indalo to present at […]

Read More

BioGenerator Company Arch Oncology Closes $50M Series B to Develop Best in Class Anti-CD-47 Therapies

Mar 25, 2019

BRISBANE, Calif. and ST. LOUIS–(BUSINESS WIRE)–Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on the discovery and development of best-in-class anti-CD47 antibody therapies, today announced a successful $50 million Series […]

Read More

Latest Tweets

Getting Started

Entrepreneurs Investors